APC and colorectal carcinoma: For the most common forms of CRC, mutational loss of the Adenomatous Polyposis Coli (APC) tumor suppressor gene, leading to WNT/β-catenin (CTNNB1) pathway activation, is followed by mutations activating KRAS and inactivating TP53 during progression [2, 3].